Exploring Pathological Mechanisms and Pharmacological Interventions in Acute Myocardial Infarction and Acute Heart Failure

Acute cardiac diseases, such as Acute Myocardial Infarction (AMI) and Acute Heart Failure (AHF), are significant global health concerns, contributing to high morbidity and mortality rates. AMI occurs due to reduced or blocked blood flow to the myocardium and is categorized into several types depending on underlying causes and clinical presentation. The pathological mechanisms involve interactions between atherosclerosis, thrombus formation, and ischemic cascades leading to myocardial cell death. AHF, characterized by the sudden worsening of heart failure symptoms, involves left ventricular dysfunction, fluid retention, and redistribution. Pharmacological interventions for AMI include immediate reperfusion, antithrombotic therapies, and long-term management with antiplatelets, anticoagulants, and vasodilators. AHF management primarily involves diuretics, inotropes, and vasodilators. This review article provides the pathological mechanisms, current pharmacological interventions for AMI and AHF, and future directions in their management.